参考文献/References:
[1]BAI L,HUO B,CHEN Z,et al.Effect of Huayu Tongluo herbs on reduction of proteinuria via inhibition of wnt/β-catenin signaling pathway in diabetic rats[J].Evid Based Complement,2017:3054145.
[2]BAI Y,WU C,HONG W,et al.Anti-fibrotic effect of sedum sarmentosum bunge extract in kidneys via the hedgehog signaling pathway[J].Mol Med,2017,16:737-745.
[3]LIU X Y,ZHANG X B,ZHAO Y F,et al.Research progress of chinese herbal medicine intervention in renal interstitial fibrosis[J].Front Pharmacol,2022,13(13):900491.
[4]成晓萍,魏钢,于小勇,等.益血降浊汤治疗慢性肾脏病4期疗效观察[J].陕西中医,2013,34(8):950-952.
[5]PALUMBO-ZERR K,ZERR P,DISTLER A,et al.Orphan nuclear receptor NR4 A1 regulates transforming growth factor-β signaling and fibrosis[J].Nat Med,2015,21:150-158.
[6]ISAKA Y.Targeting TGF-beta signaling in kidney fibrosis[J].Int J Mol Sci,2018,19(9):2532.
[7]LI Z,HONG Z,PENG Z,et al.Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway[J].Hum Cell,2018,31(3):199-209.
[8]WU J S,SHI R,LU X,et al.Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice[J].PLoS One,2015,10(3):e0122661.
[9]CHEN Y,LIN X,ZHENG Y,et al.Dendrobium mixture ameliorates diabetic nephropathy in db/db mice by regulating the TGF-β1/smads signaling pathway[J].Evid Based Complement Alternat Med,2021,30:9931983.
[10]ZUO C,XIE X S,QIU H Y,et al.Astragalus mongholicus ameliorates renal fibrosis by modulating HGF and TGF-beta in rats with unilateral ureteral obstruction[J].J Zhejiang Univ Sci B,2009,10(5):380-390.
[11]林玉洁,张成亮,王林琳,等.固本通络汤联合血液透析治疗急性肾衰竭临床研究[J].陕西中医,2025,46(4):467-471.
[12]吴斯琦,丁萌譞,舒占钧.参芪地黄汤加味对脂多糖诱导人肾小管上皮细胞TLRs/NF-κB信号通路的影响[J].陕西中医,2025,46(3):320-324.
[13]唐晨思,向广生,张翠娜,等.健脾益肾通络汤对IgA肾病患者肾功能、炎症因子的影响[J].陕西中医,2024,45(11):1499-1503.
[14]HUANG Y R,WEI Q X,WAN Y G,et al.Ureic clearance granule,alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats,compared with enalapril[J].Journal of Ethnopharmacology,2014,155(3):1541-1552.
[15]WANG L,CHI Y F,YUAN Z T,et al.Astragaloside Ⅳ inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro[J].Experimental Biology and Medicine,2014,239(10):1310-1324.
[16]CHALKIA A,GAKIOPOULOU H,THEOCHARI I,et al.TGF-β1/Smad Signalling in proliferative glomerulonephritis associated with autoimmune diseases[J].Mediterr J Rheumatol,2022,33(2):176-184.
[17]DERYNCK R,JARRETT J A,CHEN E Y,et al.Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells[J].Nature.1985,316(6030):701-715.
[18]WU M,MELICHIAN DS,CHANG E,et al.Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma[J].Am J Pathol,2009,174(2):519-533.
[19]LONG Y,CHEN W,DU Q,et al.Ubiquitination in scleroderma fibrosis and its treatment[J].Front Immunol,2018,17(9):2383.
[20]DENNLER S,GOUMANS M J,TEN DIJKE P.Transforming growth factor beta signal transduction[J].J Leukoc Biol,2002,71(5):731-740.
[21]BUDI E H,DUAN D,DERYNCK R.Transforming growth factor-β receptors and smads:Regulatory complexity and functional versatility[J].Trends Cell Biol,2017,27(9):658-672.
[22]CHEN L,YANG T,LU D W,et al.Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment[J].Biomed Pharmacother,2018,101:670-681.
[23]LAN H Y.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation[J].Int J Biol Sci,2011,7(7):1056-1067.
[24]WANG W,KOKA V,LAN H Y.Transforming growth factor-beta and Smad signalling in kidney diseases[J].Nephrology (Carlton),2005,10(1):48-56.
[25]LAN H Y.Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells[J].Curr Opin Nephrol Hypertens,2003,12:25-29.